Takeda makes changes to organisation
pharmafile | June 22, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing |Â Â TakedaÂ
Takeda has announced the change of senior leadership and the establishment of a new organisation.
Effective from July Masahiro Fujimaki becomes VP, Corporate Strategy Department. Yoshinori Ikeura will be VP, General Manager Office, Pharmaceutical Research Division; and Masayuki Ii becomes senior director, Inflammation Drug Discovery Unit, Pharmaceutical Research Division.
The new organisation comprises a General Manager Office in the Pharmaceutical Research Division. A Strategic Planning Office, Research Alliance Office, Project Management Office and Research Communication Office will be positioned under it; changing their name into Strategic Planning, Alliance, Project Management and Communication.
Related Content

Von Willebrand disease – increasing awareness and access to vital care
Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about …

Combination treatments: Takeda’s Implementation Framework and the broader landscape
Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment …

Takeda presents positive results from trial of chronic kidney disease treatment
Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat …






